News

Using liquid biopsies to test for ESR1 mutations in breast cancer is more feasible for patients and has quicker turnaround ...
SAN ANTONIO -- Among patients with estrogen receptor (ER)-positive, HER2-negative advanced breast cancer, treatment with ...